BD (NYSE:BDX) shares rose today on fourth-quarter results that came in ahead of the consensus forecast.
The Franklin Lakes, New Jersey-based medtech posted profits of $242 million, or 84¢ per share, on sales of $5.1 billion for the three months ended Sept. 30, 2021, more than doubling its bottom line on sales growth of 7.3%.
